Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 41.3639.52115.92-94.85-1,170.52

What is the latest Core EBITDA Growth ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Growth ratio of BROOKS LABORATORIES is 41.36 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202641.36
Mar202539.52
Mar2024115.92
Mar2023-94.85
Mar2022-1,170.52

How is Core EBITDA Growth of BROOKS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 41.36
4.66
Mar2025 39.52
-65.91
Mar2024 115.92
Positive
Mar2023 -94.85
Negative
Mar2022 -1170.52 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Growth ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹173.5 Cr 6% -10.8% -55.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,861.0 Cr -2% -6.1% 12.9% Stock Analytics
DIVIS LABORATORIES ₹254,319.0 Cr 3.2% 5.3% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,153.0 Cr -1.9% -2.9% 32.7% Stock Analytics
CIPLA ₹107,406.0 Cr -1.5% -4% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,362.0 Cr -2.7% 4.2% -1.2% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

6%

-10.8%

-55.5%

SENSEX

0.2%

-4.6%

-9.6%


You may also like the below Video Courses